Fairjourney Biologics acquires Charles River Laboratories South San Francisco facility

FHS
March 5, 2025
3:55 am

FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the South San Francisco site from Charles River Laboratories International, Inc.

Medicare will continue its cautious approach to paying for Alzheimer’s drugs

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

September 26, 2024

Imbalances in NET homeostasis linked to portal vein thrombosis in CHB-related decompensated cirrhosis

Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic markers.

November 12, 2024

Opioid-Free Discharge After Pancreatic Resection Can Be Achieved, Study Shows

Inpatient oral morphine equivalents (OMEs) were halved and median discharge OMEs were reduced to zero for pancreatic resection patients at a single center after two

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.